Health Condition 1: H353- Degeneration of macula and posterior pole
Conditions
Interventions
Intervention1: Group A: 15 patient will be administered Rasayan ghan vati 500 mg tablet twice a day with madhu and ghrita and ksheer sarpi nasya in 3 sittings of 7 days each with 7 days gap for 45 day
Sponsors
National Institute of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients between age of 40 to 70 years.2. Willing to sign the informed consent form, follows study instructions and complete all study visits. 3. Patients presenting with classical sign and symptoms of Pitta Vidagdha Drishti & evidence of Dry ARMD (i.e, presence of drusens or pigmentary changes in macula).
Exclusion criteria
Exclusion criteria: Ophthalmic- 1. Presence of any other retinal or macular pathology other than Non-Exudative ARMD such as Exudative ARMD, Diabetic retinopathy, Central geographic atrophy, Haemorrhagic condition of fundus or retinal fluid. 2. History of retinal laser or surgical therapy in study eye. 3. Contraindication of pupil dilatation in the study eye. 4. Mature cataract or media opacification in either eye which limits an adequate view of fundus. 5. Unable to maintain stable fixation for OCT imagining. Systemic- Disorders other than ocular conditions such as uncontrolled hypertension, uncontrolled diabetes mallitus, severe cardiac diseases, and deranged lipid profile.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in visual acuity & Number and size of drusens in the maculaTimepoint: 46 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in color vision Change in metamorphopsia (Amsler grid test findings) Changes in fundus examination Timepoint: 46 days | — |
Countries
India
Contacts
Public ContactDr Shikha Sharma
National Institute of Ayurveda
Outcome results
None listed